Matches in SemOpenAlex for { <https://semopenalex.org/work/W2412050997> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W2412050997 endingPage "8" @default.
- W2412050997 startingPage "132" @default.
- W2412050997 abstract "Presentation of the file prognostically highly unfavourable group cancers of breast.Retrospective analysis.Department of Gynaecology and Obstetrics, Faculty of Medicine, Masaryk University and Faculty Hospital, Brno.In the study, we retrospectively analyzed 47 patients with triple negative breast cancer, who have undergone in the period 2005-2008 complete treatment and then follow-up in Department of Gynaecology and Obstetrics, Faculty of Medicine, Masaryk University and Faculty Hospital, Brno. 2/3 patients underwent primary surgery followed by adjuvant therapy, 1/3 patients underwent neoadjuvant chemotherapy followed by surgery and eventually adjuvant therapy. Then patients were transferred to follow-up.Approximatelly 2/3 patients were diagnosed in early stages I and IIA FIGO, other patients in advanced stages, even though almost 90% of women participated regularly in mammography screening. With neoadjuvant chemotherapy was achieved complete pathological remission in 15% patients, in 70% patients reduction volume of the tumor at least 50%, other patients were resistant to chemotherapy. Recurrence of disease was detected by almost 39% of patients on condition follow-up at least 30 months after completion of primary treatment. Patients, who were diagnosed and treated in early stages, suffered more frequently from local recurrence and interval of recurrence from completion of primary treatment was longer. Patients, who were diagnosed and treated in advanced stages, suffered more frequently from remote metastasis and interval of recurrence from completion primary treatment was shorter.Triple negative cancers of breast are highly aggressive tumors with poor prognosis. They often are associated with lymphadenopathy and characterized by frequent occurrence of local recurrences and high risk of remote metastases. These tumors represent a large part of so-called interval cancers. Tumors often occurs in young women with BRCA1 mutations. Elementary systemic treatment is chemotherapy. Together continues the effort of highly targeted therapy, based on new findings in genomics and proteomics and on detection of many markers expressed by this version of breast cancer." @default.
- W2412050997 created "2016-06-24" @default.
- W2412050997 creator A5021131909 @default.
- W2412050997 creator A5051631099 @default.
- W2412050997 creator A5053569505 @default.
- W2412050997 creator A5085385609 @default.
- W2412050997 date "2012-04-01" @default.
- W2412050997 modified "2023-10-18" @default.
- W2412050997 title "[Triple negative breast cancer--prognostically highly unfavourable group cancer of breast]." @default.
- W2412050997 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22702070" @default.
- W2412050997 hasPublicationYear "2012" @default.
- W2412050997 type Work @default.
- W2412050997 sameAs 2412050997 @default.
- W2412050997 citedByCount "0" @default.
- W2412050997 crossrefType "journal-article" @default.
- W2412050997 hasAuthorship W2412050997A5021131909 @default.
- W2412050997 hasAuthorship W2412050997A5051631099 @default.
- W2412050997 hasAuthorship W2412050997A5053569505 @default.
- W2412050997 hasAuthorship W2412050997A5085385609 @default.
- W2412050997 hasConcept C10885799 @default.
- W2412050997 hasConcept C121608353 @default.
- W2412050997 hasConcept C126322002 @default.
- W2412050997 hasConcept C141071460 @default.
- W2412050997 hasConcept C143998085 @default.
- W2412050997 hasConcept C167135981 @default.
- W2412050997 hasConcept C2776694085 @default.
- W2412050997 hasConcept C2779234561 @default.
- W2412050997 hasConcept C2780110267 @default.
- W2412050997 hasConcept C3018227240 @default.
- W2412050997 hasConcept C530470458 @default.
- W2412050997 hasConcept C54355233 @default.
- W2412050997 hasConcept C71924100 @default.
- W2412050997 hasConcept C86803240 @default.
- W2412050997 hasConceptScore W2412050997C10885799 @default.
- W2412050997 hasConceptScore W2412050997C121608353 @default.
- W2412050997 hasConceptScore W2412050997C126322002 @default.
- W2412050997 hasConceptScore W2412050997C141071460 @default.
- W2412050997 hasConceptScore W2412050997C143998085 @default.
- W2412050997 hasConceptScore W2412050997C167135981 @default.
- W2412050997 hasConceptScore W2412050997C2776694085 @default.
- W2412050997 hasConceptScore W2412050997C2779234561 @default.
- W2412050997 hasConceptScore W2412050997C2780110267 @default.
- W2412050997 hasConceptScore W2412050997C3018227240 @default.
- W2412050997 hasConceptScore W2412050997C530470458 @default.
- W2412050997 hasConceptScore W2412050997C54355233 @default.
- W2412050997 hasConceptScore W2412050997C71924100 @default.
- W2412050997 hasConceptScore W2412050997C86803240 @default.
- W2412050997 hasIssue "2" @default.
- W2412050997 hasLocation W24120509971 @default.
- W2412050997 hasOpenAccess W2412050997 @default.
- W2412050997 hasPrimaryLocation W24120509971 @default.
- W2412050997 hasRelatedWork W1563147852 @default.
- W2412050997 hasRelatedWork W1971562495 @default.
- W2412050997 hasRelatedWork W2337097076 @default.
- W2412050997 hasRelatedWork W2364515834 @default.
- W2412050997 hasRelatedWork W2369039771 @default.
- W2412050997 hasRelatedWork W2370076106 @default.
- W2412050997 hasRelatedWork W2406129529 @default.
- W2412050997 hasRelatedWork W2534174115 @default.
- W2412050997 hasRelatedWork W3031200888 @default.
- W2412050997 hasRelatedWork W4283517943 @default.
- W2412050997 hasVolume "77" @default.
- W2412050997 isParatext "false" @default.
- W2412050997 isRetracted "false" @default.
- W2412050997 magId "2412050997" @default.
- W2412050997 workType "article" @default.